Epigenetics Market Revenue 2024 to 2034
Epigenetics Market Revenue 2024 to 2034
The epigenetics market size is forecasted to expand from USD 19.55 billion in 2025 to USD 70.51 billion by 2034, growing at a CAGR of 15.32% from 2025 to 2034.
Report ID: 10247
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 16.95 Bn
Forecast Year,
USD USD 70.51 Bn
CAGR, 2025 -
15.32%
Report Coverage
Worldwide
Published By
Yogesh Kulkarni
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Epigenetics Market Size Analysis
Epigenetics Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reagents | 4.18 | 4.77 | 5.49 | 6.44 | 7.52 | 8.63 | 9.98 | 11.60 | 13.23 | 15.40 | 17.58 |
| Kits | 4.31 | 5.04 | 5.82 | 6.66 | 7.64 | 9.00 | 10.30 | 11.91 | 13.72 | 15.73 | 17.89 |
| Instruments | 2.59 | 3.02 | 3.42 | 3.95 | 4.59 | 5.28 | 6.14 | 7.09 | 8.20 | 9.36 | 10.93 |
| Enzymes | 1.68 | 1.98 | 2.29 | 2.60 | 2.97 | 3.38 | 3.93 | 4.58 | 5.28 | 6.00 | 6.98 |
| Services | 4.18 | 4.74 | 5.52 | 6.34 | 7.25 | 8.28 | 9.52 | 10.80 | 12.59 | 14.65 | 17.11 |
Epigenetics Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA Methylation | 4.25 | 4.98 | 5.82 | 6.74 | 7.89 | 9.12 | 10.49 | 11.87 | 13.38 | 15.48 | 17.95 |
| Histone Methylation | 2.54 | 2.89 | 3.34 | 3.86 | 4.52 | 5.15 | 5.98 | 7.01 | 8.20 | 9.53 | 10.92 |
| Histone Acetylation | 2.53 | 2.89 | 3.31 | 3.83 | 4.37 | 5.08 | 5.89 | 6.89 | 8.04 | 9.21 | 10.42 |
| Large non-coding RNA | 1.67 | 1.96 | 2.30 | 2.66 | 3.03 | 3.48 | 3.90 | 4.46 | 5.16 | 6.04 | 7.04 |
| MicroRNA Modification | 2.52 | 2.85 | 3.25 | 3.66 | 4.22 | 4.94 | 5.71 | 6.60 | 7.69 | 8.70 | 10.23 |
| Chromatin Structures | 3.44 | 3.98 | 4.53 | 5.24 | 5.95 | 6.80 | 7.90 | 9.14 | 10.54 | 12.17 | 13.96 |
Epigenetics Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 11.90 | 13.77 | 15.98 | 18.62 | 21.49 | 24.65 | 28.56 | 32.93 | 38.19 | 44.09 | 50.61 |
| Non-oncology | 5.05 | 5.77 | 6.56 | 7.37 | 8.49 | 9.92 | 11.30 | 13.04 | 14.82 | 17.05 | 19.90 |
Epigenetics Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Academic Research | 4.25 | 4.89 | 5.63 | 6.48 | 7.53 | 8.64 | 10.05 | 11.40 | 13.33 | 15.14 | 17.42 |
| Clinical Research | 3.43 | 4.02 | 4.63 | 5.39 | 6.14 | 7.10 | 8.14 | 9.51 | 10.87 | 12.75 | 14.40 |
| Hospitals & Clinics | 3.41 | 3.91 | 4.52 | 5.24 | 6.02 | 6.95 | 7.95 | 9.10 | 10.45 | 11.98 | 13.94 |
| Pharmaceutical & Biotechnology Companies | 4.14 | 4.74 | 5.53 | 6.31 | 7.28 | 8.39 | 9.65 | 11.34 | 12.90 | 14.88 | 17.37 |
| Other Users | 1.71 | 1.99 | 2.24 | 2.58 | 3.01 | 3.49 | 4.08 | 4.63 | 5.46 | 6.38 | 7.36 |
Epigenetics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 6.80 | 7.84 | 9.13 | 10.44 | 11.95 | 13.68 | 15.60 | 17.91 | 20.87 | 24.45 | 28.53 |
| Asia Pacific | 4.53 | 5.26 | 5.95 | 6.89 | 8.04 | 9.33 | 10.86 | 12.57 | 14.34 | 16.41 | 18.57 |
| Europe | 3.76 | 4.33 | 5.03 | 5.86 | 6.78 | 7.89 | 9.16 | 10.55 | 12.06 | 13.65 | 15.75 |
| Latin America | 1.03 | 1.17 | 1.33 | 1.53 | 1.73 | 2.00 | 2.32 | 2.69 | 3.10 | 3.52 | 4.10 |
| Middle East and Africa | 0.83 | 0.96 | 1.11 | 1.28 | 1.48 | 1.68 | 1.92 | 2.26 | 2.65 | 3.11 | 3.56 |
Epigenetics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
